MarketBeat reported the stock consensus rating for Olema Pharmaceuticals.
2 reports, 1 independent
Updated Sep 11
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reported the stock consensus rating for Olema Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Olema Pharmaceuticals (United States)
company in San Francisco, United States
Nothing else this week.
Related events
- MarketBeat reported the stock consensus rating for Phunware on September 8, 2026.
- MarketBeat reported an average stock rating for Superior Group of Companies.
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- MarketBeat reported recent stock ratings for Innovative Solutions and Support, Inc. and TechPrecision Corporation.
- MarketBeat reported on the stock performance of Allarity Therapeutics, Inc. on September 1, 2026.
Coverage
Newest first; wire copies grouped- dailypolitical.comOlema Pharmaceuticals (NASDAQ:OLMA) Downgraded by Wall Street Zen to “Strong Sell”